menu
    • menu

    Company profile for Axial Therapeutics

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Axial Therapeutics™ is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. The company is leveraging its expertise in the gut-brain axis and its unique drug development platform to advance novel therapies that have the potential to transform the treatment paradigm in neurodegenerative diseases. Axial The...
    Axial Therapeutics™ is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. The company is leveraging its expertise in the gut-brain axis and its unique drug development platform to advance novel therapies that have the potential to transform the treatment paradigm in neurodegenerative diseases. Axial Therapeutics is uniquely positioned to advance a fundamentally different therapeutic approach for the treatment of neurological diseases and disorders

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Axial TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Tradecenter Drive Suite 6990 Woburn, MA 01801
    Telephone
    Telephone
    +1 781-701-8484
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.axialtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/axial-biotherapeutics-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Axial Rebrands, Refocuses And Raises $20M
    Axial Rebrands, Refocuses And Raises $20M

    21 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/exit-axial-enter-vertero-biotech-rebrands-refocuses-and-raises-20m

    FIERCE PHARMA
    21 Oct 2025
    Share Share
    Milestone Scientific Partners With Axial Biologics To Distribute CompuFlo
    Milestone Scientific Partners With Axial Biologics To Distribute CompuFlo

    07 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/07/2926069/15852/en/Milestone-Scientific-Announces-Strategic-Partnership-with-Axial-Biologics-to-Distribute-CompuFlo-in-New-Jersey-Texas-and-Florida.html

    GLOBENEWSWIRE
    07 Aug 2024
    Share Share
    Axial Therapeutics to Present at Upcoming Conferences
    Axial Therapeutics to Present at Upcoming Conferences

    05 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/05/2804626/0/en/Axial-Therapeutics-to-Present-at-Upcoming-Conferences.html

    GLOBENEWSWIRE
    05 Jan 2024
    Share Share
    Axial Announces Completion of Enrollment in Phase 2b Trial for AB-2004
    Axial Announces Completion of Enrollment in Phase 2b Trial for AB-2004

    26 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/26/2749423/0/en/Axial-Therapeutics-Announces-Completion-of-Enrollment-in-Global-Phase-2b-Clinical-Trial-for-AB-2004-for-Irritability-Associated-with-Autism.html

    GLOBENEWSWIRE
    26 Sep 2023
    Share Share
    Axial Therapeutics Receives Second Research Grant Award AX-5006 for PD
    Axial Therapeutics Receives Second Research Grant Award AX-5006 for PD

    20 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/20/2691013/0/en/Axial-Therapeutics-Receives-Second-Research-Grant-Award-from-The-Michael-J-Fox-Foundation-to-Further-Support-Advancement-of-AX-5006-for-Parkinson-s-Disease.html

    GLOBENEWSWIRE
    20 Jun 2023
    Share Share
    Axial Announces Age Expansion in Phase 2b Trial for Irritability Associated
    Axial Announces Age Expansion in Phase 2b Trial for Irritability Associated

    04 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/04/2640627/0/en/Axial-Therapeutics-Announces-Age-Expansion-in-Global-Phase-2b-Clinical-Trial-for-Irritability-Associated-with-Autism-Spectrum-Disorder-ASD.html

    GLOBENEWSWIRE
    04 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search